Tag: Treatment-Resistant Depression
-
New Frontiers in Treating Treatment-Resistant Depression: Vagus Nerve Stimulation and Beyond
Overview: The Rising Need for Neuromodulation in MDD Major depressive disorder (MDD) remains a global health challenge, with a significant subset of patients — up to 35% — not responding after four or more standard treatment trials. In the face of this treatment resistance, researchers and clinicians are turning to neuromodulation as a viable alternative…
-
Vagus Nerve Stimulation Offers Fresh Outlook for Treatment-Resistant Depression: Conference Report
Introduction: A Growing Challenge in Depression Care Major depressive disorder (MDD) remains a leading cause of disability worldwide. In a clinical landscape where up to 35% of patients do not respond to four or more standard treatments, researchers and clinicians are exploring innovative neuromodulation approaches. Vagus nerve stimulation (VNS) is gaining renewed attention as a…
-
Vagus Nerve Stimulation in TRD: New Lines of Thinking
Understanding the Crisis of Treatment-Resistant Depression Major depressive disorder (MDD) remains a leading cause of disability worldwide, and a substantial subset of patients fail to respond after multiple treatment attempts. Conference discussions centered on Vagus Nerve Stimulation (VNS) as a promising neuromodulation option for those with treatment-resistant depression (TRD). With up to 35% of patients…
-
Ketamine Therapy: A Misunderstood Medicine Finds Its Place in Modern Care
Understanding Ketamine Therapy in Modern Depression Care For many people living with depression, the journey to relief can be long and uncertain. Traditional antidepressants and therapy work for some, but others continue to struggle despite trying multiple options. Ketamine therapy, including the FDA-approved form esketamine (Spravato), has emerged as a promising option in the modern…
-
Ketamine Therapy: A Modern Depression Solution with Esketamine
Introduction: A Misunderstood Medicine, A Modern Approach For many people living with depression, the path to relief can be winding and uncertain. Traditional antidepressants help some, but others experience persistent symptoms despite several trials. Ketamine therapy, alongside the FDA-approved esketamine (Spravato), is reshaping conversations about what’s possible in modern psychiatric care. When administered in the…